1 |
Eldecalcitol-Zwischenprodukt A |
200636-54-0 |
Eldecalcitol |
|
2 |
Eldecalcitol Intermediates CD |
144848-24-8 |
Eldecalcitol |
|
3 |
Eldecalcitol-Zwischenprodukt |
200636-42-6 |
Eldecalcitol |
|
4 |
4-Chlor-3-(trifluormethyl)phenylisocyanat |
327-78-6 |
Sorafenib |
|
5 |
N-Methyl-4-chlorpyridin-2-carboxamid |
220000-87-3 |
Sorafenib |
|
6 |
Terephthalsäuremonomethylester |
1679-64-7 |
Bexaroten |
|
7 |
1,2,3,4-tetrahydro-1,1,4,4,6-pentamethyl-naphthalene |
6683-48-3 |
Bexarotene |
|
8 |
Methyl-4-[(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)carbonyl]benzoat |
153559-45-6 |
Bexaroten |
|
9 |
Benzoesäure, 4-[1-Hydroxy-1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethyl] |
852524-20-0 |
Bexaroten |
|
10 |
Methyl-4-(chlorcarbonyl)benzoat |
7377-26-6 |
Bexaroten |
|
11 |
(4s,5r)-3-tert-butoxycarbony-2-(4-anisyl)-4-phenyl-5-oxazolidincarbonsäure |
196404-55-4 |
Docetaxel |
|
12 |
7,10-o-Ditroc-Docetaxel |
114915-14-9 |
Docetaxel |
|
13 |
Methyl(2r,3s)-n-tert-butoxycarbonyl-3-phenylisoserinat |
124605-42-1 |
Docetaxel |
|
14 |
5-Fluor-2-oxindol |
56341-41-4 |
Sunitinib |
|
15 |
N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide |
356068-86-5 |
Sunitinib |
|
16 |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamin |
152460-10-1 |
Imatinib |
|
17 |
4-[(4-Methylpiperazin-1-yl)methyl]benzoesäuredihydrochlorid |
106261-49-8 |
Imatinib |
|
18 |
Ethyl4,5-bis(2-methoxyethoxy)-2-aminobenzoat |
179688-27-8 |
Erlotinib |
|
19 |
Ethyl4,5-bis(2-methoxyethoxy)-2-nitrobenzoat |
179688-26-7 |
Erlotinib |
|
20 |
Ethyl-3,4-bis(2-methoxyethoxy)benzoat |
183322-16-9 |
Erlotinib |
|
21 |
Ethyl 3,4-dihydroxybenzoate |
3943-89-3 |
Erlotinib |
|
22 |
6,7-Bis-(2-methoxyethoxy)-4(3h)-chinazolinon e |
179688-29-0 |
Erlotinib |
|
23 |
2-(Methylsulfonyl)ethylamin HCl |
104458-24-4 |
Lapatinib |
|
24 |
3-Chlor-4-(3-fluorbenzyloxy)anilin |
202197-26-0 |
Lapatinib |
|
25 |
6-Iodoquinazolin-4-ol |
16064-08-7 |
Lapatinib |
|
26 |
N-[3-Chlor-4-(3-fluorbenzyloxy)phenyl]-6-i odochinazolin-4-amin |
231278-20-9 |
Lapatinib |
|
27 |
4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamidmonomethansulfonat |
388082-78-8 |
Lapatinib |
|
28 |
2-Amino-5-iod-benzoesäure |
5326-47-6 |
Lapatinib |
|
29 |
4-Chlor-6-iod-chinazolin |
98556-31-1 |
Lapatinib |
|
30 |
2-Chlor-1-(3-fluorbenzyloxy)-4-nitrobenzol |
443882-99-3 |
Lapatinib |
|
31 |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluormethyl)anilin |
641571-11-1 |
Nolotinib |
|
32 |
3-[(Aminoiminomethyl)amino]-4-methylbenzoesäureethylestermononitrat |
641569-96-2 |
Nolotinib |
|
33 |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoesäure |
641569-94-0 |
Nolotinib |
|
34 |
2,3,5-Tri-o-benzyl-d-arabinofuranose-1-(4-nitrobenzoat) |
52522-49-3 |
Fludarabinphosphat |
|
35 |
(R)-2,3-o-Isopropylidenglycerinaldehyd |
15186-48-8 |
Gemcitabin |
|
36 |
2-Desoxy-2,2-difluor-3,5-o-dibenzoylribosemesylat |
122111-11-9 |
Gemcitabin |
|
37 |
2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate |
153012-08-9 |
Gemcitabine |
|
38 |
2-Desoxy-2’,2’-difluor-3’5’-bis-o-benzoyleytidin-Monohydrochlorid |
134790-39-9 |
Gemcitabin |
|
39 |
2-Desoxy-2,2-difluor-D-erythro-pentofuranos-1-ulose-3,5-dibenzoat |
122111-01-7 |
Gemcitabin |
|
40 |
3,5-Di-o-benzoyl-2-desoxy-2,2-difluor-1-o-methansulfonyl-d-ribofuranose |
134877-43-3 |
Gemcitabin |
|
41 |
Ethylbromdifluoracetat |
667-27-6 |
Gemcitabin |
|
42 |
Methansulfonylchlorid |
124-63-0 |
Gemcitabin |
|
43 |
N-Acetyl-n,o-bis-(trimethylsilyl)-cytosin |
N/A |
Gemcitabin |
|
44 |
1,2,3-3-o-Acetyl-5-desoxy-d-ribofuranose |
62211-93-2 |
Capecitabin |
|
45 |
2',3'-Di-o-acetyl-5'-desoxy-5-fluorcytidin |
161599-46-8 |
Capecitabin |
|
46 |
5'-Desoxy-5-fluor-n-[(pentyloxy)carbonyl]cytidin-2',3'-diacetat |
162204-20-8 |
Capecitabin |
|
47 |
4-(1-Piperidino)piperidin; 1,4'-Bipiperidin |
4897-50-1 |
Irinotecan |
|
48 |
1,4'-Bipiperidin]-1'-carbonylchlorid HCl |
143254-82-4 |
Irinotecan |
|
49 |
7-Ethyl-10-(chlorcarbonyloxy)camptothe cin |
N/A |
Irinotecan |
|
50 |
7-Ethyl-10-hydroxycamptothecin |
86639-52-3 |
Irinotecan |
|
51 |
7-Ethylcamptothecin |
78287-27-1 |
Irinotecan |
|
52 |
Camptothecin |
7689-03-4 |
Irinotecan |
|
53 |
N-(8-Amino-6-fluor-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalin-2-yl)acetamid |
182182-31-6 |
Exatecan |
|
54 |
(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizin-3,6,10(4h)-trion |
110351-94-5 |
Exatecan |
|
55 |
1h-1,2,4-Triazol |
288-88-0 |
Letrozol |
|
56 |
4-(1h-1,2,4-triazol-1-ylmethyl)-benzonitrin |
112809-25-3 |
Letrozol |
|
57 |
4-(Brommethyl)-benzonitril |
17201-43-3 |
Letrozol |
|
58 |
4-Fluorbenzonitril |
1194-02-1 |
Letrozol |
|
59 |
2-bromo-ethanesulfonic acid |
26978-65-4 |
Mesna |
|
60 |
Thioharnstoff |
62-56-6 |
Fleischig |
|
61 |
(2r,3s)-3-Phenylisoserinhydrochlorid |
132201-32-2 |
Paclitaxe |
|
62 |
(2r,3s)-3-Phenylisoserinmethylester |
131968-74-6 |
Paclitaxe |
|
63 |
2,4-Diamino-6-hydroxypyrimidin |
56-06-4 |
Pemetrexed |
|
64 |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1h-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoesäure |
137281-39-1 |
Pemetrexed |
|
65 |
Diethyl-L-Glutamat-Hydrochlorid |
1118-89-4 |
Pemetrexed |
|
66 |
1,2-Dipalmitoyl-sn-glycerin |
30334-71-5 |
Mifamurtide |
|
67 |
1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamin |
923-61-5 |
Mifamurtide |
|
68 |
3-(4-Chlorbutyl)-1H-indol-5-carbonitril |
143612-79-7 |
Vilazodon |
|
69 |
2-Benzofurancarboxamide, 5-(1-Piperazinyl)- |
183288-46-2 |
Vilazodon |
|
70 |
5-(1-Piperazinyl)-2-benzofurancarbonsäureethylesterhydrochlorid |
765935-67-9 |
Vilazodon |
|
71 |
Ethyl 5-aminobenzofuran-2-carboxylate |
174775-48-5 |
Vilazodone |
|
72 |
3-Nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzolsulfonaMide |
1228779-96-1 |
Venetoclax (ABT-199) |
|
73 |
2-[(1H-Pyrrolo[2,3-B]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorphenyl)-4,4-dimethylring Hex-1-enyl] Methyl]piperazin-1-yl]benzoesäure |
1235865-77-6 |
Venetoclax (ABT-199) |
|
74 |
5-[4-((3-Chlor-4-((3-fluorbenzyl)oxy)phenyl)amino)chinazolin-6-yl]-2-furaldehyd |
231278-84-5 |
Lapatinib |
|
75 |
Abirateron |
154229-19-3 |
Abirateronacetat |
|
76 |
Bortezomib Intermediate A |
179324-87-9 |
Bortezomib intermediates |
|
77 |
Isobutaneboronic acid |
84110-40-7 |
Bortezomib intermediates |
|
78 |
Baricitinib Impurity 81 |
1146629-77-7 |
Baricitinib intermediates |
|
79 |
Baricitinib intermediate 2 |
1187595-85-2 |
Baricitinib intermediates |
|
80 |
Abiraterone |
154229-19-3 |
Abiraterone acetate intermediates |
|